Drug Database
LY

lysine salicylate (lysine salicylate / Dolorosan)

✓ Approved

VUFB · 小分子 · 小分子

什么是 lysine salicylate?

lysine salicylate 是一种小分子,由VUFB研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名lysine salicylate, Dolorosan
公司VUFB
药物类别小分子
给药途径Unknown
状态Approved

治疗适应症

lysine salicylate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersAbdominal pain✓ Approved

相关研究文献

PubMedBiotechnology advances2026-08-04

ε-Poly-l-lysine biomanufacturing advances: From biosynthesis to specification-grade products and applications.

Zhu Daojun D, Li Shangyu S, Zheng Lei L, Zhang Hongjian H et al.

ε-Poly-l-lysine (ε-PL) is transitioning from a food preservative to a bio-based cationic functional scaffold with opportunities spanning food, agriculture, and biomaterials. However, progress in the field is hampered by a persistent disconnect between titer-driven manufacturing optimization and performance-driven application development. To bridge this gap, we propose a specification-driven (spec-driven) framework that uses critical quality attributes (CQAs) to link molecular structure, industrial production, and application translation. First, we define a minimal, actionable set of ε-PL CQAs and map their molecular determinants to functional relevance. Next, we delineate the biological feasibility windows and constraints that govern these CQAs under high-throughput biosynthesis. We then synthesize integrated strain, process, and recovery engineering strategies to illustrate how CQAs can be translated into reproducible industrial specifications. Finally, application requirements are reverse-mapped to the CQA combinations most frequently required across use scenarios. We conclude that while titer remains important, further gains in titer alone are insufficient to unlock broad translation. Among the proposed CQAs, chain-length distribution, impurity profile, and manufacturing consistency are particularly critical because they determine functional performance, safety boundaries, and lot-to-lot reproducibility. Accordingly, chain-length control, impurity reduction, and integrated strain-process-downstream control represent key rate-limiting steps for developing specification-grade ε-PL product families.

PMID 42546810
阅读全文 →
PubMedChemistry (Weinheim an der Bergstrasse, Germany)2026-08-04

From Caffeine to Aspirin: Everyday Molecules as Triggers for Genetically Encoded Proximity Systems.

Cui Mingguang M, Wang Tianlu T, Han Yaoyu Y, Huang Yun Y et al.

Chemically induced proximity (CIP) enables programmable control of gene expression, protein activity, cellular signaling, and engineered cell functions using small molecules. Yet many classical CIP platforms rely on ligands that may limit therapeutic translation owing to unfavorable biosafety profiles, off-target activity, incomplete reversibility, dosing constraints, and potential immunogenicity of engineered components. This perspective highlights dietary small molecule- and OTC drug-responsive CIP systems as emerging platforms for translational chemogenetic control. We focus on two complementary design strategies. One exploits nanobody-derived binders against familiar small molecules, as exemplified by synthetic anti-caffeine nanobody-based systems. The other adapts naturally evolved ligand-binding proteins through rational protein engineering, as illustrated by salicylate-responsive platforms derived from plant salicylic acid (SA)-binding receptors for reversible proximity control and aspirin-responsive gene regulation. Together, these engineered systems demonstrate how familiar molecules such as caffeine, SA, and aspirin can be transformed into programmable biological inputs. We further discuss how artificial intelligence (AI)-guided protein engineering may expand this design space by enabling de novo construction and functional reprogramming of ligand-responsive modules, leading to safer and clinically compatible proximity-control systems.

PMID 42548045
阅读全文 →
PubMedKidney research and clinical practice2026-08-04

Unlocking potassium secretion: the roles of aldosterone, ROMK, and WNK kinases in kidney potassium handling.

Palmer Biff F BF

The normal human kidney possesses a prodigious capacity to excrete dietary potassium (K+). This evolutionary adaptation is rooted in the high-K+ diets of prehistoric hominids, which are estimated to have reached 15,000 mg/day. Despite the progressive reduction in dietary K+ since the advent of agriculture, the modern distal nephron remains an exquisite K+ sensor. This review elucidates the molecular mechanisms governing kidney K+ handling, tracing the pathway from early enteric sensing to the structural reorganization of WNK (with-no-lysine [K+] kinase), and detailing how the interplay between aldosterone and angiotensin II ultimately resolves the aldosterone paradox in the distal nephron.

PMID 42548167
阅读全文 →
PubMedCurrent opinion in toxicology2026-08-04

NGRA in Cosmetic Safety: Moving From the Frameworks and Case Studies to Wide Adoption.

Rusyn Ivan I, Chiu Weihsueh A WA, Dent Matthew M, Middleton Alistair A

The cosmetic safety evaluation has undergone a paradigm shift driven by animal testing bans now implemented across countries representing one-third of the global population and nearly half of worldwide cosmetics sales. The legislative mandates have accelerated the development and adoption of Next Generation Risk Assessment (NGRA), an innovative framework that proposes making of context-specific safety decisions using exposure-driven, mechanism-based approaches based on non-animal test methods. Significant progress has been achieved in replacing animal tests for specific endpoints including skin sensitization, irritation, and phototoxicity through validated New Approach Methodologies (NAMs). However, major gaps remain for one-for-one replacement of systemic toxicity, reproductive and developmental toxicity, and carcinogenicity animal tests. Recent advances demonstrate that NGRA can successfully address many of these complex endpoints through integrated approaches combining physiologically-based kinetic (PBK) modeling, high-throughput transcriptomics and in vitro phenotyping to derive Bioactivity-Exposure Ratios (BERs) for risk characterization. Numerous case studies across diverse chemical types, including coumarin, benzophenone-4, caffeine, and benzyl salicylate, have demonstrated NGRA's utility for making protective safety decisions without animal data. These examples highlight critical considerations that need to be addressed in NGRA, including metabolite assessment, dose metric selection, and quantitative uncertainty characterization. While like-for-like replacement of all animal tests remains unachievable, NGRA provides a scientifically robust pathway for protective assessments where an absence of systemic effects is the primary goal, particularly for cosmetic ingredients. The challenge now lies in harmonizing methodologies, building regulatory confidence in these approaches, and evolving institutional structures to enable routine NGRA implementation across global regulatory regimes.

PMID 42549259
阅读全文 →
PubMedDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections2026-08-04

Comparative Analysis of the Amino Acid Spectrum of Blood Plasma in Adults and Juveniles of the Pond Bat (Myotis dasycneme Boie, 1825) from Natural Populations of the Urals.

Kovalchuk L A LA, Chernaya L V LV, Mikshevich N V NV, Bolshakov V N VN

Field and laboratory studies were performed to assess the age-related characteristics of the amino acid spectrum of blood plasma in pond bats (Myotis dasycneme Boie, 1825) from natural populations of the Urals. A comparative analysis of the free amino acid pool content in the blood plasma of adult and juvenile (subadult) female pond bats during the summer period of their annual life cycle is presented for the first time. The plasma amino acid pool of the pond bat, regardless of age, comprised 22 amino acids and their derivatives, including the full spectrum of functionally significant essential amino acids: threonine, valine, lysine, leucine, isoleucine, methionine, phenylalanine, arginine, histidine, and tryptophan. An assessment was made of the interconnected role of the blood system and free amino acids in animals in shaping the species adaptive strategy in response to both seasonal variation in the annual life cycle and pathogens of natural and zoonotic significance.

PMID 42550419
阅读全文 →
PubMedMolecular and biochemical parasitology2026-08-04

Why Not Now? Targeting Plasmodium falciparum histone methyltransferases for next-generation antimalarial strategies.

Parthiban Ezhumalai E, Ramanibai Ravichandran R, Ramachandran Maduraiveeran M

Plasmodium falciparum is the major human malaria parasite and its treatment remains challenging, with current artemisinin-based combination therapies increasingly compromised by emerging resistance in several regions. Although the pre-erythrocytic vaccines, Mosquirix and R21, are recommended only for children under five years of age in highly endemic African regions, their protective efficacy is moderate and wanes over time, underscoring the continued need for effective antimalarial drugs. Epigenetic mechanisms play a central role in regulating the parasite genome in response to diverse host environments, with methyltransferases acting as key components that dynamically modulate chromatin structure to control stage-specific gene expression. These epigenetic factors critically shape parasite fate by governing the expression of surface antigens, including var, RIFINs and STEVORs, thereby enabling immune evasion and the establishment of chronic infections. To date, no therapeutics specifically targeting histone lysine methyltransferases (HKMTs) have reached clinical use, although BIX-01294 has been explored as a candidate antimalarial in preclinical studies. This review synthesizes current knowledge on Plasmodium HKMTs, highlighting their biochemical activities, regulatory roles, and contributions to virulence. While evaluating emerging epigenetic inhibitors as potential antimalarial agents. We further discuss the main challenges in developing such therapies, emphasizing the necessity of detailed structural characterization, optimized pharmacological properties and rigorous validation of candidate compounds across Plasmodium species to enable successful translation.

PMID 42546906
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多lysine salicylate